Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Publication year range
1.
Cancer Radiother ; 18(3): 211-4, 2014 Jun.
Article in French | MEDLINE | ID: mdl-24819246

ABSTRACT

The main histological types of cervix cancer are squamous cell carcinoma and adenocarcinoma. The glassy cell carcinoma is a rare form found in less than 2% of cases and it is an entity, aggressive and unknown, of worse prognosis, whose current treatment is not distinguished from other histological types. We report the cases of two patients with glassy cell carcinoma of the cervix with a review of the literature.


Subject(s)
Carcinoma, Adenosquamous/pathology , Rare Diseases/pathology , Uterine Cervical Neoplasms/pathology , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Adenosquamous/therapy , Combined Modality Therapy , Fatal Outcome , Female , Humans , Hysterectomy , Lymph Node Excision , Lymphatic Metastasis , Magnetic Resonance Imaging , Radiotherapy, Conformal , Rare Diseases/therapy , Uterine Cervical Neoplasms/therapy
2.
Gynecol Obstet Fertil ; 37(9): 749-51, 2009 Sep.
Article in French | MEDLINE | ID: mdl-19682939

ABSTRACT

We report a case of ruptured ovarian molar pregnancy, diagnosed in the context of haemorragic shock 19 days following evacuation of an intrauterine hydatiform mole. To our knowledge, this is the first reported case of heterotopic molar pregnancy.


Subject(s)
Hydatidiform Mole/diagnosis , Pregnancy Complications, Neoplastic/diagnosis , Shock, Hemorrhagic/etiology , Uterine Neoplasms/diagnosis , Abdominal Pain/etiology , Adult , Dilatation and Curettage , Female , Humans , Hydatidiform Mole/complications , Hydatidiform Mole/therapy , Pregnancy , Pregnancy Complications, Neoplastic/therapy , Uterine Neoplasms/complications , Uterine Neoplasms/therapy
3.
Gynecol Obstet Fertil ; 37(2): 109-14, 2009 Feb.
Article in French | MEDLINE | ID: mdl-19200764

ABSTRACT

OBJECTIVES: The presenting symptoms of leiomyosarcoma (LMS) are the same as those of leiomyoma. The diagnosis of LMS is usually achieved retrospectively after pathological analysis of hysterectomy specimens. The aim of surgery in uterine sarcomas being resection without tumor morcellation, LMS poses the problem of the choice of surgical route because it is more likely to occur in relatively young women. This study was undertaken to determine, firstly, the frequency of LMS in a series of hysterectomies performed for presumed leiomyomas, secondly, if there exist any particular context in which LMS should be considered and how this may modify the choice of surgical route, thirdly, to discuss about the therapeutical aspects of those cases of LMS diagnosed incidentally after uterine morcellation. PATIENTS AND METHODS: A retrospective review, from 1996 to 2005, of cases of LMS diagnosed retrospectively in patients having benefited from hysterectomy for presumed leiomyomas, at the department of Obstetrics-Gynaecology, Belfort Hospital. RESULTS: From 1996 to 2005, 1297 hysterectomies have been performed for presumed leiomyomas in our department. Patients' mean age was 48 years (34 to 77 years). Menometrorraghia was the most common symptom having motivated surgery (57%), followed by pelvic pain (31%) and the notion of a rapidly growing uterine mass (12%). The distribution of surgical route was as follows: laparotomic route, n=393 (30%); vaginal route, n=855 (66%) and laparoscopic assisted vaginal route, n=49 (4%). Pathological analysis had revealed LMS in three patients (0.23%). DISCUSSION AND CONCLUSION: LMS is usually diagnosed incidentally on hysterectomy specimen analysis. Indeed, the surgeon may find himself in a therapeutic dilemma in cases where vaginal extraction has required tumour morcellation with an increased risk of peritoneal and/or vaginal dissemination. However, given the extremely low incidence of LMS in series of hysterectomies performed for presumed leiomyomas and the lack of specific preoperative context to clearly evoke this diagnosis, the fear of leiomyosarcoma should not make us apprehend nonlaparotomic surgical routes.


Subject(s)
Hysterectomy/methods , Leiomyoma/surgery , Leiomyosarcoma/surgery , Uterine Neoplasms/surgery , Adult , Age Factors , Aged , Diagnosis, Differential , Female , Humans , Leiomyoma/diagnosis , Leiomyoma/pathology , Leiomyosarcoma/diagnosis , Leiomyosarcoma/epidemiology , Leiomyosarcoma/pathology , Middle Aged , Retrospective Studies , Uterine Neoplasms/diagnosis , Uterine Neoplasms/pathology
4.
Article in French | MEDLINE | ID: mdl-19111997

ABSTRACT

Rhabdomyosarcoma (RMS) of the uterine corpus is rare in adult females. This tumor can be encountered in two distinct histopathological contexts: usually as a component of a malignant mixed mullerian tumor and exceptionally as a pure heterologous sarcoma. We report two cases of pure RMS of the uterine corpus occurring in postmenopausal women. The two patients suffered from vaginal bleeding and preoperative diagnosis was achieved in both cases. Both patients benefited from exploratory laparotomy, total hysterectomy and bilateral salpingo-oophorectomy. Both of them were free from the disease 15 months and 1 year respectively, after initial surgery. These two observations are worthy of publication because pure RMS of the uterine corpus is exceptional in postmenopausal women.


Subject(s)
Rhabdomyosarcoma/diagnosis , Uterine Hemorrhage/etiology , Uterine Neoplasms/diagnosis , Aged , Diagnosis, Differential , Female , Humans , Hysterectomy , Postmenopause , Rhabdomyosarcoma/pathology , Rhabdomyosarcoma/surgery , Treatment Outcome , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery
5.
Gynecol Obstet Fertil ; 36(6): 628-35, 2008 Jun.
Article in French | MEDLINE | ID: mdl-18538624

ABSTRACT

OBJECTIVE: Sarcoma of the uterus are rare uterine cancers with poor prognosis. They are characterised by pathological diversity and their symptomatology is not specific. The aim of this study was to review our experience with uterine sarcomas, to analyze their clinical and histopathological features, to discuss about diagnostic and therapeutic difficulties associated with these tumours and to compare our findings with previously published data. PATIENTS AND METHODS: A retrospective review, from 1996 to 2005, of cases of uterine sarcomas diagnosed and treated at the department of obstetrics-gynaecology, Belfort Hospital. Clinical and pathological features, types of treatment, tumoral stage according to the FIGO histological classification and patients' outcome were recorded. RESULTS: From 1996 to 2005, 15 cases of uterine sarcomas have been diagnosed in our department. Our study included six histological types: carcinosarcoma (n=5), leiomyosarcoma (n=3), rhabdomyosarcoma (n=2), adenosarcoma (n=2), stromal sarcoma (n=2), and undifferentiated sarcoma (n=1). Patients' mean age at the time of diagnosis was 67.6 years (range: 48-91 years). Vaginal bleeding was the most common presenting symptom, being present in 10 patients (67%). The mean time from onset of symptomatology and pathological diagnosis of sarcoma was 17.1 weeks (range: one to 60 weeks). In 10 patients (67%), definitive diagnosis of sarcoma was achieved only after surgical specimen analysis and in only three of them (30%), physical examination combined with pelvic ultrasonography had suspected malignancy. Dilation and curettage was performed in nine patients and failed to rule out neoplasia in three cases (33.5%). Fourteen patients (93%) underwent surgery: total hysterectomy with bilateral salpingo-oophorectomy in all of them and pelvic lymphadenectomy in four of them. Eight patients were in FIGO stage I, one patient in stage II, three patients in stage III and two patients in stage IV. Six patients benefited from adjuvant treatment: external beam radiotherapy and brachytherapy in three cases, brachytherapy in one case and chemotherapy in two cases. At the time of analysis, four patients were lost to follow-up, four patients were dead and with an average follow-up of 25 months, seven patients had a favourable outcome. DISCUSSION AND CONCLUSION: Uterine sarcomas are rare cancers with poor prognosis. Their symptomatology is non-specific and they are characterized by histopathological diversity. Early diagnosis is essential because patients' survival is correlated to tumour stage. However, preoperative diagnosis is often difficult and definitive diagnosis is frequently achieved after pathological analysis of hysterectomies specimens.


Subject(s)
Chemotherapy, Adjuvant , Hysterectomy/methods , Ovariectomy/methods , Radiotherapy, Adjuvant , Sarcoma/pathology , Uterine Neoplasms/pathology , Aged , Aged, 80 and over , Female , Humans , Middle Aged , Neoplasm Staging , Prognosis , Retrospective Studies , Sarcoma/mortality , Sarcoma/surgery , Sarcoma/therapy , Survival Rate , Time Factors , Treatment Outcome , Uterine Neoplasms/mortality , Uterine Neoplasms/surgery , Uterine Neoplasms/therapy
6.
Diagn Mol Pathol ; 8(3): 157-64, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10565688

ABSTRACT

The purpose of this study was to evaluate the clinical use of the Hybrid Capture (HC)-II system for the detection of human papillomavirus (HPV) DNA to identify women at risk of progression to high grade squamous intraepithelial lesions (HGSIL) and carcinomas by differentiating low risk (LR) HPV types (6, 11, 42, 43, 44) and high/intermediate risk (HR) HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68). Five hundred and ninety-six women were enrolled in the study. Among them, 466 attended the hospital for routine cytologic screening and 130 were referred for colposcopy because of an abnormal Pap smear. The presence of HPV DNA was tested in cervical samples collected with the Digene Cervical Sampler in Digene Specimen Transport Medium (Digene Corporation, Silver Spring, MD, U.S.A.) using the HC-II assay. Results were compared with those obtained by polymerase chain reaction (PCR) using the MY09-MY11 primers followed by several hybridizations with specific probes. The overall HPV positivity was 32.9% by HC-II and 37.8% by PCR. Among cytologically normal smears, 19.5% were positive by HC-II (14.3% HR) and 25.1% by PCR. Of the atypical squamous cells of undetermined significance samples, 52.9% were positive by HC-II (41.1% HR) and 55.9% by PCR. Of the low grade SIL, 64.5% were positive by HC-II (59.4% HR) and 68.7% by PCR. The HPV positivity rate was found identical by both techniques in high grade smears (81.6%) and squamous cervical carcinomas (100%). By using PCR as the reference method, the sensitivity of HC-II was higher among women with abnormal cytology than with normal cytology (87.3% vs. 70%). Specificity was 80.8% and 97.5%, respectively. In summary, these results indicate that the HC-II method and MY-PCR identified nearly equivalent prevalences of HPV in cervical smear specimens.


Subject(s)
Carcinoma, Squamous Cell/pathology , Papillomaviridae , Papillomavirus Infections/pathology , Tumor Virus Infections/pathology , Uterine Cervical Neoplasms/pathology , Adolescent , Adult , Carcinoma, Squamous Cell/virology , Colposcopy , DNA, Viral/analysis , Female , Humans , Mass Screening , Middle Aged , Nucleic Acid Hybridization/methods , Papanicolaou Test , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Polymerase Chain Reaction/methods , Reference Values , Regression Analysis , Reproducibility of Results , Uterine Cervical Neoplasms/virology , Vaginal Smears
7.
Article in French | MEDLINE | ID: mdl-2313069

ABSTRACT

The authors report a new case of menstrual pneumothorax and pelvic endometriosis which was discovered at this time. In this case (because of the presence of lesions suggesting the condition on thoracotomy) the probable mechanism thought to cause this pneumothorax would be the cyclical shedding of pleural endometriotic lesions. The authors review the characteristics of this unusual syndrome and base their review on an analysis of the hundred cases reported in the literature. They show that there are two theories of pathogenicity classically held. The first is the existence of congenital gaps in the diaphragm which allow air to pass into the pleura during the periods, the other is the possibility of endometriotic pleural lesions damaging the cortex of the lung as they shed their cells during the period.


Subject(s)
Endometriosis/complications , Menstruation Disturbances/complications , Pelvic Neoplasms/complications , Pneumothorax/etiology , Adult , Endometriosis/pathology , Female , Humans , Pelvic Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL